"True" Antiphospholipid Syndrome in COVID-19: Contribution of the Follow-up of Antiphospholipid Autoantibodies

Semin Thromb Hemost. 2023 Feb;49(1):97-102. doi: 10.1055/s-0042-1758118. Epub 2022 Nov 6.

Robin Arcani^{1

2}, Raphaël Cauchois^{1

2}, Pierre Suchon³, Samuel Weber⁴, Rodolphe Jean¹, Pierre-André Jarrot^{1

2}, Louise Rey⁴, Geoffroy Venton⁵, Marie Koubi¹, Romain Muller^{1

2}, Daniel Bertin⁴, Jean-Louis Mège^{4

6}, Gilles Kaplanski^{1

2}, Nathalie Bardin^{2

4}

¹ Department of Internal Medicine and Clinical Immunology, CHU La Conception, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
² Aix-Marseille University, INSERM, INRAE, C2VN, Marseille, France.
³ Hematology Laboratory, CHU La Timone, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
⁴ Service d'Immunologie, Pôle de Biologie, Hôpital de la Conception, Assistance Publique-Hôpitaux de Marseille (AP-HM), France.
⁵ Department of Hematology and Cellular Therapy, CHU La Conception, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
⁶ Aix-Marseille University, IRD, MEPHI, IHU-Méditerranée Infection, Marseille, France.

No abstract available

MeSH terms